An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before directing customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.
Several experts stated the popularity for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.
Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach medicines, advertising, and customer laws, risking fines, legal action or imprisonment.
Service Response and Material Elimination
According to TikTok, the platform has removed violative content and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Trading Activities
Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, glowing reviews and detailed guides for mixing or injecting at residence.
Within minutes of joining one group, a seller shared contact information, where most transactions occur. The seller provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.
Product Information and Costs
Within these groups, posts display black plastic packages with Royal Mail stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they can’t verify. Although the science behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious health risks”.
